Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.775 USD | +2.03% | +3.03% | +12.80% |
25/04 | Shareholder Capital asks Vanda Pharma's board to reconsider Future Pak's offer | RE |
22/04 | Vanda Pharmaceuticals Appeal for Patents on Sleep Drug Declined by US Supreme Court | MT |
Business Summary
Number of employees: 203
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapies
100.0
%
| 254 | 100.0 % | 193 | 100.0 % | -24.27% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 254 | 100.0 % | 193 | 100.0 % | -24.27% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 01/02/01 | |
Kevin Moran
DFI | Director of Finance/CFO | 40 | 01/12/01 |
Scott Howell
HRO | Human Resources Officer | - | 01/19/01 |
Kim Wijkstrom
SAM | Sales & Marketing | 57 | 21/19/21 |
Tim Williams
LAW | General Counsel | 48 | 13/18/13 |
Corporate Officer/Principal | 55 | 01/03/01 | |
Corporate Officer/Principal | 73 | 01/05/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Richard W. Dugan
BRD | Director/Board Member | 82 | 01/05/01 |
Chief Executive Officer | 64 | 01/02/01 | |
Director/Board Member | 72 | 14/20/14 | |
Director/Board Member | 52 | 28/19/28 | |
Phaedra Chrousos
BRD | Director/Board Member | 44 | 24/19/24 |
Tage Honoré
BRD | Director/Board Member | - | 15/23/15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 58,197,773 | 56,457,336 ( 97.01 %) | 0 | 97.01 % |
Company contact information
Vanda Pharmaceuticals, Inc.
2200 Pennsylvania Avenue NW Suite 300E
20037, Washington
+202 734 3400
http://www.vandapharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.80% | 272M | |
-1.64% | 103B | |
+7.57% | 101B | |
+4.40% | 23.07B | |
-12.18% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.70% | 16.94B | |
+6.78% | 14.07B | |
+37.94% | 12.35B |
- Stock Market
- Equities
- VNDA Stock
- Company Vanda Pharmaceuticals Inc.